Suppr超能文献

基因治疗及其在皮肤病学中的应用。

Gene Therapy and its Application in Dermatology.

作者信息

Sarkar Tanusree, Sarkar Somenath, Gangopadhyay Dwijendra Nath

机构信息

Department of Dermatology, Burdwan Medical College, West Bengal, India.

Department of Dermatology, B. S Medical College, West Bengal, India.

出版信息

Indian J Dermatol. 2020 Sep-Oct;65(5):341-350. doi: 10.4103/ijd.IJD_323_20.

Abstract

Gene therapy is an experimental technique to treat genetic diseases. It is based on the introduction of nucleic acid with the help of a vector, into a diseased cell or tissue, to correct the gene expression and thus prevent, halt, or reverse a pathological process. It is a promising treatment approach for genetic diseases, inherited diseases, vaccination, cancer, immunomodulation, as well as healing of some refractory ulcers. Both viral and nonviral vectors can be used to deliver the correct gene. An ideal vector should have the ability for sustained gene expression, acceptable coding capacity, high transduction efficiency, and devoid of mutagenicity. There are different techniques of vector delivery, but these techniques are still under research for assessment of their safety and effectiveness. The major challenges of gene therapy are immunogenicity, mutagenicity, and lack of sustainable therapeutic benefit. Despite these constraints, therapeutic success was obtained in a few genetic and inherited skin diseases. Skin being the largest, superficial, easily accessible and assessable organ of the body, may be a promising target for gene therapy research in the recent future.

摘要

基因治疗是一种治疗遗传疾病的实验技术。它基于借助载体将核酸导入患病细胞或组织,以纠正基因表达,从而预防、阻止或逆转病理过程。对于遗传疾病、遗传性疾病、疫苗接种、癌症、免疫调节以及一些难治性溃疡的愈合而言,它是一种很有前景的治疗方法。病毒载体和非病毒载体均可用于递送正确的基因。理想的载体应具备持续基因表达能力、可接受的编码容量、高转导效率且无致突变性。存在不同的载体递送技术,但这些技术仍在研究中以评估其安全性和有效性。基因治疗的主要挑战包括免疫原性、致突变性以及缺乏可持续的治疗益处。尽管存在这些限制,但在一些遗传性和遗传性皮肤病中已取得了治疗成功。皮肤作为人体最大、最浅表、易于触及和评估的器官,在不久的将来可能成为基因治疗研究的一个有前景的靶点。

相似文献

1
Gene Therapy and its Application in Dermatology.
Indian J Dermatol. 2020 Sep-Oct;65(5):341-350. doi: 10.4103/ijd.IJD_323_20.
2
Recent advances in nonviral vectors for gene delivery.
Acc Chem Res. 2012 Jul 17;45(7):971-9. doi: 10.1021/ar200151m. Epub 2011 Aug 26.
4
7
Contemporary approaches for nonviral gene therapy.
Discov Med. 2015 Jun;19(107):447-54.
8
Biomaterial-based gene therapy.
MedComm (2020). 2023 Jun 3;4(3):e259. doi: 10.1002/mco2.259. eCollection 2023 Jun.
9
[Precise application of Traditional Chinese Medicine in minimally-invasive techniques].
Zhongguo Gu Shang. 2018 Jun 25;31(6):493-496. doi: 10.3969/j.issn.1003-0034.2018.06.001.
10
Opportunities and challenges for the clinical translation of structured DNA assemblies as gene therapeutic delivery and vaccine vectors.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Jan;13(1):e1657. doi: 10.1002/wnan.1657. Epub 2020 Jul 15.

引用本文的文献

1
Exosomes as natural vectors for therapeutic delivery of bioactive compounds in skin diseases.
Front Pharmacol. 2025 Apr 28;16:1485769. doi: 10.3389/fphar.2025.1485769. eCollection 2025.
2
A Truncated Mutation of TP53 Promotes Chemoresistance in Tongue Squamous Cell Carcinoma.
Int J Mol Sci. 2025 Mar 6;26(5):2353. doi: 10.3390/ijms26052353.
3
Overview of familial syndromes with increased skin malignancies.
Arch Dermatol Res. 2023 May;315(4):707-727. doi: 10.1007/s00403-022-02447-8. Epub 2022 Nov 7.
4
The Emerging Therapeutic Targets for Scar Management: Genetic and Epigenetic Landscapes.
Skin Pharmacol Physiol. 2022;35(5):247-265. doi: 10.1159/000524990. Epub 2022 Jun 13.
5
Future Perspectives of Oral Delivery of Next Generation Therapies for Treatment of Skin Diseases.
Pharmaceutics. 2021 Oct 18;13(10):1722. doi: 10.3390/pharmaceutics13101722.

本文引用的文献

1
Clinical Advances in Human Gene Therapies.
JAMA. 2018 Jan 9;319(2):113. doi: 10.1001/jama.2017.20692.
4
Engineering Human Stem Cell Lines with Inducible Gene Knockout using CRISPR/Cas9.
Cell Stem Cell. 2015 Aug 6;17(2):233-44. doi: 10.1016/j.stem.2015.06.001. Epub 2015 Jul 2.
6
Gene therapies for inherited skin disorders.
Semin Cutan Med Surg. 2014 Jun;33(2):83-90. doi: 10.12788/j.sder.0085.
7
CRISPR-Cas systems for editing, regulating and targeting genomes.
Nat Biotechnol. 2014 Apr;32(4):347-55. doi: 10.1038/nbt.2842. Epub 2014 Mar 2.
8
TALEN-based gene correction for epidermolysis bullosa.
Mol Ther. 2013 Jun;21(6):1151-9. doi: 10.1038/mt.2013.56. Epub 2013 Apr 2.
9
Gene therapy clinical trials worldwide to 2012 - an update.
J Gene Med. 2013 Feb;15(2):65-77. doi: 10.1002/jgm.2698.
10
RNA-guided human genome engineering via Cas9.
Science. 2013 Feb 15;339(6121):823-6. doi: 10.1126/science.1232033. Epub 2013 Jan 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验